NM_018941.4:c.374A>G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_018941.4(CLN8):​c.374A>G​(p.Asn125Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00118 in 1,614,122 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N125I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00084 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 0 hom. )

Consequence

CLN8
NM_018941.4 missense

Scores

3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:9B:5O:1

Conservation

PhyloP100: 1.30

Publications

10 publications found
Variant links:
Genes affected
CLN8 (HGNC:2079): (CLN8 transmembrane ER and ERGIC protein) This gene encodes a transmembrane protein belonging to a family of proteins containing TLC domains, which are postulated to function in lipid synthesis, transport, or sensing. The protein localizes to the endoplasmic reticulum (ER), and may recycle between the ER and ER-Golgi intermediate compartment. Mutations in this gene are associated with a disorder characterized by progressive epilepsy with cognitive disabilities (EPMR), which is a subtype of neuronal ceroid lipofuscinoses (NCL). Patients with mutations in this gene have altered levels of sphingolipid and phospholipids in the brain. [provided by RefSeq, Jul 2017]
CLN8 Gene-Disease associations (from GenCC):
  • neuronal ceroid lipofuscinosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • neuronal ceroid lipofuscinosis 8
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • neuronal ceroid lipofuscinosis 8 northern epilepsy variant
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • autism spectrum disorder
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011771888).
BP6
Variant 8-1771428-A-G is Benign according to our data. Variant chr8-1771428-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 205207.
BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.00122 (1778/1461890) while in subpopulation SAS AF = 0.00213 (184/86258). AF 95% confidence interval is 0.00188. There are 0 homozygotes in GnomAdExome4. There are 920 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_018941.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN8
NM_018941.4
MANE Select
c.374A>Gp.Asn125Ser
missense
Exon 2 of 3NP_061764.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN8
ENST00000331222.6
TSL:1 MANE Select
c.374A>Gp.Asn125Ser
missense
Exon 2 of 3ENSP00000328182.4Q9UBY8
KBTBD11-OT1
ENST00000635855.1
TSL:5
n.374A>G
non_coding_transcript_exon
Exon 2 of 30ENSP00000489726.1A0A1B0GTJ5
CLN8
ENST00000519254.2
TSL:5
c.374A>Gp.Asn125Ser
missense
Exon 2 of 3ENSP00000490016.1Q9UBY8

Frequencies

GnomAD3 genomes
AF:
0.000841
AC:
128
AN:
152112
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.0000944
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00122
Gnomad OTH
AF:
0.000959
GnomAD2 exomes
AF:
0.000974
AC:
245
AN:
251482
AF XY:
0.00118
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000925
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.00117
Gnomad OTH exome
AF:
0.000651
GnomAD4 exome
AF:
0.00122
AC:
1778
AN:
1461890
Hom.:
0
Cov.:
32
AF XY:
0.00127
AC XY:
920
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.000149
AC:
5
AN:
33480
American (AMR)
AF:
0.000961
AC:
43
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00213
AC:
184
AN:
86258
European-Finnish (FIN)
AF:
0.000150
AC:
8
AN:
53420
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5768
European-Non Finnish (NFE)
AF:
0.00132
AC:
1463
AN:
1112008
Other (OTH)
AF:
0.00101
AC:
61
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
119
239
358
478
597
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000841
AC:
128
AN:
152232
Hom.:
0
Cov.:
32
AF XY:
0.000766
AC XY:
57
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.000361
AC:
15
AN:
41570
American (AMR)
AF:
0.00124
AC:
19
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.00166
AC:
8
AN:
4820
European-Finnish (FIN)
AF:
0.0000944
AC:
1
AN:
10594
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00122
AC:
83
AN:
68010
Other (OTH)
AF:
0.000949
AC:
2
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
5
11
16
22
27
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00113
Hom.:
0
Bravo
AF:
0.000956
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00105
AC:
9
ExAC
AF:
0.000815
AC:
99
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.00120
EpiControl
AF:
0.00136

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
2
1
Neuronal ceroid lipofuscinosis 8 (5)
-
3
1
not provided (4)
-
-
2
Neuronal ceroid lipofuscinosis (2)
-
1
1
not specified (2)
-
1
-
Inborn genetic diseases (1)
-
1
-
Intellectual disability (1)
-
1
-
Neuronal ceroid lipofuscinosis 8;C1864923:Neuronal ceroid lipofuscinosis 8 northern epilepsy variant (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.055
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
0.61
DANN
Benign
0.42
DEOGEN2
Uncertain
0.47
T
Eigen
Benign
-0.94
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.29
N
LIST_S2
Benign
0.74
T
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-0.52
T
MutationAssessor
Benign
1.7
L
PhyloP100
1.3
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.96
N
REVEL
Benign
0.28
Sift
Benign
0.28
T
Sift4G
Uncertain
0.016
D
Polyphen
0.034
B
Vest4
0.71
MVP
0.81
MPC
0.035
ClinPred
0.0090
T
GERP RS
-0.080
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.022
gMVP
0.25
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142269885; hg19: chr8-1719594; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.